KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Return on Equity (2020 - 2025)

Historic Return on Equity for Royalty Pharma (RPRX) over the last 6 years, with Q4 2025 value amounting to 0.14%.

  • Royalty Pharma's Return on Equity rose 100.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.14%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.13% for FY2025, which is 0.0% changed from last year.
  • Latest data reveals that Royalty Pharma reported Return on Equity of 0.14% as of Q4 2025, which was up 100.0% from 0.14% recorded in Q3 2025.
  • Royalty Pharma's 5-year Return on Equity high stood at 0.19% for Q2 2021, and its period low was 0.02% during Q4 2022.
  • In the last 5 years, Royalty Pharma's Return on Equity had a median value of 0.12% in 2021 and averaged 0.12%.
  • Its Return on Equity has fluctuated over the past 5 years, first crashed by -1500bps in 2021, then surged by 1500bps in 2023.
  • Royalty Pharma's Return on Equity (Quarter) stood at 0.12% in 2021, then crashed by -81bps to 0.02% in 2022, then skyrocketed by 649bps to 0.17% in 2023, then dropped by -25bps to 0.13% in 2024, then increased by 6bps to 0.14% in 2025.
  • Its Return on Equity was 0.14% in Q4 2025, compared to 0.14% in Q3 2025 and 0.17% in Q2 2025.